Overview
- Legal name
- CYGNOS BIOTECH, LLC
- Registered location
- MIAMI, FL, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- May 15, 2026
Read company summary
CYGNOS BIOTECH, LLC is associated with UEI PXYDY5CQJDM3 and CAGE 8WQ76 in public federal records. AcornBids currently links 2 prime awards totaling $1.6M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists MIAMI, FL, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- CYGNOS BIOTECH, LLC
- UEI
- PXYDY5CQJDM3
- CAGE
- 8WQ76
- Registered address
- 10650 SW 137TH ST, MIAMI, FL, 33176, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Dec 25, 2025
- Initial registration
- Mar 10, 2021
- Entity start
- Jul 17, 2023
- SAM updated
- Dec 25, 2025
- Registration expires
- Dec 23, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- FL, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| W911SR26CA003THE PURPOSE OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II CONTRACT IS TO SHOW EFFICACY OF ANTI-VIRAL TREATMENT WITH THE PVX THERAPEUTIC. | Department of Defense | $1.4M | Feb 2, 2026 | Aug 1, 2027 |
| W911SR25C0013RESEARCH TO CREATE A CLASS OF AGNOSTIC DRUGS TARGETING THE HOST TO ASSIST IN FIGHTING OFF A BROAD SPECTRUM OF VIRAL PATHOGENS. | Department of Defense | $204.5K | Mar 7, 2025 | Sep 8, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Dec 25, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Mar 10, 2021 |
| Entity start | Jul 17, 2023 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| JAY YOURIST | Government business | Contact method not published | SAM registration | Not available |
| WALID M CHAAR | Electronic business | Contact method not published | SAM registration | Not available |
| JAY YOURIST | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registered products and services
- 6505 — Drugs and Biologicals
- 6509 — Drugs and Biologicals, Veterinary Use.
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit